CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of ...

Another recall has been issued for a generic version of a popular heartburn drug best known as Zantac due to the presence of a potentially cancer-causing impurity. It's the latest in several such ...

Aug 27 (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L), opens new tab and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...

The verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the Zantac multidistrict litigation. Additional Zantac jury ...

Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug. The nation's largest ...

The Food and Drug Administration announced that the popular heartburn medication Zantac, or ranitidine, and some generic versions of the medication, could have an impurity that could cause cancer. The ...